Abstract
Ultrasound has few reports on its application in prediction of microvascular invasion (MVI) in hepatocellular carcinoma (HCC). The purpose of this study was to explore the diagnostic efficacies of preoperative ultrasound and magnetic resonance imaging (MRI) for HCC MVI and compare these two imaging methods for the diagnosis of this condition. The clinical and preoperative ultrasound and MR imaging data of 26 patients with newly diagnosed HCC were collected between October 2020 and October 2021. According to the gold standard (postoperative pathology), the patients were divided into MVI-positive and MVI-negative groups, and the efficacies of ultrasound and MRI in diagnosing HCC MVI and the consistency between the two imaging modalities were analyzed. For the preoperative diagnosis of MVI using ultrasound, the sensitivity was 93.33%, the specificity was 81.82%, and the accuracy was 88.46%. For preoperative MRI, the sensitivity was 66.67%, the specificity was 100%, and the accuracy was 80.77%. In diagnosing MVI, the two methods had significantly different efficacy (P = 0.031). Ultrasound and MRI have high diagnostic efficiency for MVI, but the accuracy of preoperative MRI was lower than that of preoperative ultrasound. These results indicate that ultrasound has a certain guiding significance in the diagnosis of HCC MVI.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10142-023-01006-2/MediaObjects/10142_2023_1006_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10142-023-01006-2/MediaObjects/10142_2023_1006_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10142-023-01006-2/MediaObjects/10142_2023_1006_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10142-023-01006-2/MediaObjects/10142_2023_1006_Fig4_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10142-023-01006-2/MediaObjects/10142_2023_1006_Fig5_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10142-023-01006-2/MediaObjects/10142_2023_1006_Fig6_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10142-023-01006-2/MediaObjects/10142_2023_1006_Fig7_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs10142-023-01006-2/MediaObjects/10142_2023_1006_Fig8_HTML.png)
Similar content being viewed by others
Data availability
The datasets used during the current study are available from the corresponding author on reasonable request.
Change history
11 May 2024
This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1007/s10142-024-01376-1
Abbreviations
- BC:
-
Breast cancer
- HR :
-
Hazard ratio
- CI :
-
Confidence interval
- KM‑plot :
-
Kaplan‑Meier plotter
- OS :
-
Overall survival
- RFS :
-
Relapse‑free survival
- DMFS :
-
Distant metastasis‑free survival
- PPS :
-
Post‑progression survival
- ER :
-
Estrogen receptor
- PR :
-
Progesterone receptor
- HER2 :
-
Human epidermal growth factor receptor
- TP53 :
-
Tumor protein p53
References
Annet L, Materne R, Danse E, Jamart J, Horsmans Y, Van Beers BE (2003) Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension. Radiol 229:409–414
Ariizumi S, Kitagawa K, Kotera Y, Takahashi Y, Katagiri S, Kuwatsuru R, Yamamoto M (2011) A non-smooth tumor margin in the hepatobiliary phase of gadoxetic acid disodium (Gd-EOB-DTPA)-enhanced magnetic resonance imaging predicts microscopic portal vein invasion, intrahepatic metastasis, and early recurrence after hepatectomy in patients with hepatocellular carcinoma. J Hepatobiliary Pancreat Sci 18:575–585
Bonnin P, Villemain A, Vincent F, Debbabi H, Silvestre JS, Contreres JO, Levy BI, Tobelem G, Dupuy E (2007) Ultrasonic assessment of hepatic blood flow as a marker of mouse hepatocarcinoma. Ultrasound Med Biol 33:561–570
Choi JY, Lee JM, Sirlin CB (2014) CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects. Radiol 272:635–54
Chou CT, Chen RC, Lin WC, Ko CJ, Chen CB, Chen YL (2014) Prediction of microvascular invasion of hepatocellular carcinoma: preoperative CT and histopathologic correlation. AJR Am J Roentgenol 203:W253–W259
Erstad DJ, Tanabe KK (2019) Prognostic and therapeutic implications of microvascular invasion in hepatocellular carcinoma. Ann Surg Oncol 26:1474–1493
Hayashi M, Matsui O, Ueda K, Kawamori Y, Gabata T, Kadoya M (2002) Progression to hypervascular hepatocellular carcinoma: correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material. Radiol 225:143–149
Hong SB, Choi SH, Kim SY, Shim JH, Lee SS, Byun JH, Park SH, Kim KW, Kim S, Lee NK (2021) MRI features for predicting microvascular invasion of hepatocellular carcinoma: a systematic review and meta-analysis. Liver Cancer 10:94–106
Hui AM, Takayama T, Sano K, Kubota K, Akahane M, Ohtomo K, Makuuchi M (2000) Predictive value of gross classification of hepatocellular carcinoma on recurrence and survival after hepatectomy. J Hepatol 33:975–979
Isik B, Gonultas F, Sahin T, Yilmaz S (2020) Microvascular venous invasion in hepatocellular carcinoma: why do recurrences occur? J Gastrointest Cancer 51:1133–1136
Kanai T, Hirohashi S, Upton MP, Noguchi M, Kishi K, Makuuchi M, Yamasaki S, Hasegawa H, Takayasu K, Moriyama N et al (1987) Pathology of small hepatocellular carcinoma. A proposal for a new gross classification. Cancer 60:810–9
Kim AY, Sinn DH, Jeong WK, Kim YK, Kang TW, Ha SY, Park CK, Choi GS, Kim JM, Kwon CHD, Joh JW, Kim MJ, Sohn I, Jung SH, Paik SW, Lee WJ (2018) Hepatobiliary MRI as novel selection criteria in liver transplantation for hepatocellular carcinoma. J Hepatol 68:1144–1152
Lee S, Kim SH, Lee JE, Sinn DH, Park CK (2017) Preoperative gadoxetic acid-enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma. J Hepatol 67:526–534
Lee S, Kim KW, Jeong WK, Kim MJ, Choi GH, Choi JS, Song GW, Lee SG (2020) Gadoxetic acid-enhanced MRI as a predictor of recurrence of HCC after liver transplantation. Eur Radiol 30:987–995
Lee S, Kang TW, Song KD, Lee MW, Rhim H, Lim HK, Kim SY, Sinn DH, Kim JM, Kim K, Ha SY (2021) Effect of microvascular invasion risk on early recurrence of hepatocellular carcinoma after surgery and radiofrequency ablation. Ann Surg 273:564–571
Li X, Han X, Li L, Su C, Sun J, Zhan C, Feng D, Cheng W (2022) Dynamic contrast-enhanced ultrasonography with sonazoid for diagnosis of microvascular invasion in hepatocellular carcinoma. Ultrasound Med Biol 48:575–581
Ng IO, Lai EC, Ng MM, Fan ST (1992) Tumor encapsulation in hepatocellular carcinoma. A pathologic study of 189 cases. Cancer 70:45–9
Qiu G, ** Z, Chen X, Huang J (2020) Interpretation of guidelines for the diagnosis and treatment of primary liver cancer (2019 edition) in China. Glob Health Med 2:306–11
Renzulli M, Brocchi S, Cucchetti A, Mazzotti F, Mosconi C, Sportoletti C, Brandi G, Pinna AD, Golfieri R (2016) Can current preoperative imaging be used to detect microvascular invasion of hepatocellular carcinoma? Radiol 279:432–442
Rimola J (2020) Heterogeneity of hepatocellular carcinoma on imaging. Semin Liver Dis 40:61–69
Roayaie S, Obeidat K, Sposito C, Mariani L, Bhoori S, Pellegrinelli A, Labow D, Llovet JM, Schwartz M, Mazzaferro V (2013) Resection of hepatocellular cancer </=2 cm: results from two Western centers. Hepatol 57:1426–1435
Sheng X, Ji Y, Ren GP, Lu CL, Yun JP, Chen LH, Meng B, Qu LJ, Duan GJ, Sun Q, Ye XQ, Li SS, Yang J, Liao B, Wang ZB, Zhou JH, Sun Y, Qiu XS, Wang L, Li ZS, Chen J, **a CY, He S, Li CY, Xu EW, Geng JS, Pan C, Kuang D, Qin R, Guan HW, Wang ZD, Li LX, Zhang X, Wang H, Zhao Q, Wei B, Zhang WJ, Ling SP, Du X, Cong WM; Liver Cancer Pathology Group of China (LCPGC) (2020) A standardized pathological proposal for evaluating microvascular invasion of hepatocellular carcinoma: a multicenter study by LCPGC. Hepatol Int 14:1034–47
Suk KT, Kim EJ, Kim DJ, Kim HS, Bang CS, Park TY, Baik GH, Kim SE, Park JW, Park SH, Lee MS, Kim HS, Jang MK, Park SH, Choi E, Kim CH, Sung H, Park CK (2017) Prognostic significance of hemodynamic and clinical stages in the prediction of hepatocellular carcinoma. J Clin Gastroenterol 51:285–293
Tsuboyama T, Onishi H, Kim T, Akita H, Hori M, Tatsumi M, Nakamoto A, Nagano H, Matsuura N, Wakasa K, Tomoda K (2010) Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging–correlation with expression of sinusoidal and canalicular transporters and bile accumulation. Radiol 255:824–833
Wang Y, Liao J, Qi W, **e L, Li Y (2016) Predictive value of conventional ultrasound and contrast-enhanced ultrasound in early recurrence of hepatocellular carcinoma after surgical resection. Ultrasound Med Biol 42:1042–1048
Wei WX, Yang ZS, Lu LH, Li J, Lei ZQ, Wang K, **a Y, Yan ZL, Shen F (2018) Long-term survival after partial hepatectomy for sub-stage patients with intermediate stage hepatocellular carcinoma. Int J Surg 56:256–263
Witjes CD, Willemssen FE, Verheij J, van der Veer SJ, Hansen BE, Verhoef C, de Man RA, Ijzermans JN (2012) Histological differentiation grade and microvascular invasion of hepatocellular carcinoma predicted by dynamic contrast-enhanced MRI. J Magn Reson Imaging 36:641–647
Yamashita Y, Tsuijita E, Takeishi K, Fujiwara M, Kira S, Mori M, Aishima S, Taketomi A, Shirabe K, Ishida T, Maehara Y (2012) Predictors for microinvasion of small hepatocellular carcinoma </= 2 cm. Ann Surg Oncol 19:2027–2034
Zhao H, Hua Y, Dai T, He J, Tang M, Fu X, Mao L, ** H, Qiu Y (2017) Development and validation of a novel predictive scoring model for microvascular invasion in patients with hepatocellular carcinoma. Eur J Radiol 88:32–40
Zhou Y, He L, Huang Y, Chen S, Wu P, Ye W, Liu Z, Liang C (2017) CT-based radiomics signature: a potential biomarker for preoperative prediction of early recurrence in hepatocellular carcinoma. Abdom Radiol 42:1695–1704
Funding
Liuzhou Science and Technology Department research program (Grant No.2022CAC0108).
Author information
Authors and Affiliations
Contributions
WZ designed the study. YL, ZL, SW, BT, and QL performed data analysis. YL and ZL drafted the manuscript. WZ revised the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
This study was approved by the Institutional Ethics Committee of Guilin Medical University Affiliated Hospital.
Consent for publication
Obtained.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article has been retracted. Please see the retraction notice for more detail: https://doi.org/10.1007/s10142-024-01376-1
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Long, Y., Lv, Z., Wang, S. et al. RETRACTED ARTICLE: Comparison of preoperative ultrasound and MRI in the diagnosis of microvascular invasion in hepatocellular carcinoma. Funct Integr Genomics 23, 100 (2023). https://doi.org/10.1007/s10142-023-01006-2
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10142-023-01006-2